Information Systems Connectivity to Improve Medication Process (LinkedCare)

September 19, 2025 updated by: Peter Putz

Effects of Care Information Systems Connectivity on Medication Process Efficiency and Quality (Linked Care): Protocol for a Cluster Allocated Controlled Trial

Linked Care aims to help healthcare professionals (nurses, doctors, pharmacists) interact efficiently and safely with IT support to improve patient information flows. It focuses on the medication ordering process, which currently involves time-consuming steps like calling doctors and traveling to get prescriptions. The project targets nursing staff, doctors, pharmacists, and patients, with indirect benefits for hospitals, social welfare organizations, and insurance bodies. This study evaluates the Linked Care solution by addressing the research question: Does an electronic ordering system improve the efficiency and quality of the regular medication process?

Study Overview

Detailed Description

Background and rationale:

Linked Care aims to provide access to information relevant to care and support beyond the boundaries of the various care settings and primarily supports caregivers in the acquisition and transfer of information. The development of essential standards (e.g., a myCare Info) and the involvement of all affected target groups make it possible to develop practical IT tools for standardized networking in mobile care and nursing. The result will be an integrated, affordable, easy-to-use and well-connected IT system for care and support. The portal can be operated via mobile devices, PC, or tablets.

The McKinsey study demonstrates the significant potential of digitalization in the Austrian healthcare sector. According to this study, there is a 4.7-billion-euro opportunity for Austria. Approximately 70% of the potential benefits of increased productivity accrue to service providers, such as physicians and hospitals. The remaining 30% can be attributed to other players in the system, particularly health insurers, who benefit from reduced service utilization and improved care. Key factors in achieving these benefits include the implementation of the Austrian electronic health record (ELGA) and e-prescribing, which enable efficiency gains of EUR 690 million. Digitization is also sought after by regulators, patients, payers, and service providers in the Austrian healthcare system for improved efficiency and quicker access to data.

Helmcke et al. (2021) identify the following areas with the greatest potential for savings and benefits in the Austrian healthcare system:

  • Online interactions, especially through teleconsultation.
  • Paperless data, emphasizing standardized patient records/exchange and electronic prescriptions.
  • Automated workflows, particularly the networking of mobile caregivers.
  • Decision support and transparency of outcomes, including performance dashboards.
  • Patient self-management, primarily through tools for managing chronic conditions like diabetes.
  • Patient self-service for electronic scheduling.

Objectives:

This project aims to enable documenting healthcare professionals (such as nurses, general practitioners (GPs), and pharmacists) to interact efficiently, safely, and conveniently, with optimal IT support, to improve (or make more efficient) the patient-related information flows. The specific use cases studied are the process of ordering and in particular reordering medication. A significant time-saving potential has been identified in the transfer of medication information. The ordering process usually begins with nurses calling a GP as soon as they notice that a client has run out of medication and needs to be re-supplied when preparing the prescribed medication. The nurse then usually travels distances (e.g. by car) to obtain a prescription from the GP and collect the medication from the pharmacy. To do this, they need the client's insurance card, which has to be collected separately. The project is therefore aimed at four target groups: i) nursing staff who carry out the documentation, ii) GPs, and iii) pharmacists and finally iv) patients who make use of the care. In addition to the target groups studied in this trial, indirect beneficiaries include healthcare providers such as hospitals, social welfare organizations, rehabilitation clinics, public insurance bodies, etc. who ensure effective and efficient care. The trial aims to evaluate the entire process of data recording and data exchange via the newly created interfaces between the systems involved in practical use.

The primary research question of this study is: Does an electronic ordering system improve the efficiency and quality of the regular medication process?

Secondary research questions are:

  • Does the digital ordering system receive end-user acceptance?
  • Which impacts on the health and care system are generated by the implementation of the digital ordering system? (evaluated qualitatively)

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Linz, Austria, 4200
        • Volkshilfe Gesundheits- und Soziale Dienste GmbH
      • Vienna, Austria, 1210
        • Johanniter Österreich Ausbildung und Forschung gem. GmbH
      • Vienna, Austria, 1030
        • Wiener Rotes Kreuz- Rettungs-, Krankentransport-, Pflege- und Betreuungsgesellschaft m.b.H.
      • Vienna, Austria
        • Volkshilfe Wien gemeinnützige Betriebs-GmbH

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria Caregivers:

  • Actively pursuing at least one of the following health professions extramurally: nurse, nursing assistant level 1 or level 2 , elderly specialist caregiver, home care assistant
  • Active maintenance of nursing documentation and use of the duty cell phone
  • Age 18+ years
  • Willing to comply with all study-related procedures and provide informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention (using Linked Care system)

All nurses and caregivers participating in the intervention group use the newly installed mynevaToGo app to reorder medication. Nurses and nursing assistant level 2 also use the myneva Care Center software to keep the medication list prescribed by the GP.

The solution is installed in advance on the duty cell phones by the IT department of the relevant care organization. Participating nurses and caregivers in the intervention group are instructed to handle the medication ordering process electronically (i.e., medication orders will be sent to the GPs via the Linked Care platform).

The test system consists of:

  • Linked care platform (backend) which provides a new possibility of data exchange for IT systems of caregivers, pharmacies, and GPs
  • User interfaces for caregivers as well as for the systems myneva.carecenter and mynevaTOgo
  • An extension of the user interface for GPs in their IT system (in the test only for the physician software PCPO by CompoGroup Medical )
  • An extension of the user interface for pharmacists in their IT system (in the test only for pharmacies with software from Apothekerverlag)

Functionally, the solution should, coordinate the medication requirements between pharmacies, GPs, and caregivers (subarea medication).

Active Comparator: Control
Care professionals in the convenience sampled control group continue to handle the usual medication process.
Usual care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time spent on medication related processes
Time Frame: Baseline, 3-month follow-up, 6-month follow-up
Measure of time efficiency recorded on a project-specific 14-day medication log. / Minimum value: 0 [minutes], maximum value: N/A. Higher scores mean a worse outcome. / Analysis metric: difference test vs. control, test group trend analysis. / Method of aggregation: mean.
Baseline, 3-month follow-up, 6-month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overall score from the "Survey on psychological stress in mobile care (BGW miab)
Time Frame: Baseline, 3-month follow-up, 6-month follow-up
Self-reported indications on 6 subitems on a 5-point Likert pseudometric scale. / Minimum value: 1, maximum value: 5. Higher scores mean a worse outcome. / Analysis metric: Difference test vs. control & test group trend analysis. / Method of aggregation: mean score.
Baseline, 3-month follow-up, 6-month follow-up
Overall score from a "Project-specific questionnaire on care-process quality".
Time Frame: Baseline, 3-month follow-up, 6-month follow-up
Self-reported indications on 21 subitems on a 5-point Likert pseudometric scale. / Minimum value: 1, maximum value: 5. Higher scores mean a worse outcome. / Analysis metric: Difference test vs. control & test group trend analysis. / Method of aggregation: weighted mean score.
Baseline, 3-month follow-up, 6-month follow-up
Overall score from the "Usefulness, Satisfaction, and Ease of Use (PSSUQ) Questionnaire"
Time Frame: 3-month follow-up, 6-month follow-up
Self-reported indications on 16 subitems on a 7-point Likert pseudometric scale. / Minimum value: 1, maximum value: 7. Higher scores mean a worse outcome. / Analysis metric: Difference test vs. control & test group trend analysis. / Method of aggregation: mean score.
3-month follow-up, 6-month follow-up
Overall score from the "Unified Theory of Acceptance and Use of Technology 2 (UTAUT2) Questionnaire"
Time Frame: 3-month follow-up, 6-month follow-up
Self-reported indications on a 7-point Likert pseudometric scale with subitems in 4 domains: i) performance expectancy, ii) effort expectancy, iii) social influence, and iv) facilitating conditions. / Minimum value: 1, maximum value: 7. Higher scores mean a worse outcome. / Analysis metric: Difference test vs. control & test group trend analysis. / Method of aggregation: mean score.
3-month follow-up, 6-month follow-up

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sample Characteristic Affiliation
Time Frame: Baseline
Affiliation to a care-providing organization (selection from 4 participating organizations GSD, VHW, WRK, JOHA). Scale: nominal.
Baseline
Sample Characteristic Profession
Time Frame: Baseline
Profession (selection from 5 options: certified nurse, specialist nursing assistant, nursing assistant level 1 or level 2 , home care assistant. Scale: nominal.
Baseline
Sample Characteristic Age
Time Frame: Baseline
Age (years). Scale: metric.
Baseline
Sample Characteristic Gender
Time Frame: Baseline
Gender (selection from 3 options: male, female, divers). Scale: nominal.
Baseline
Sample Characteristic Employment Extent
Time Frame: Baseline
Employment extent (weekly contractual hours). Scale: metric.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Helmcke Stefan, Biesdorf Stefan, Bauer Florian, Berger Wernhard (2021). mckinseystudiedigitalisierung im gesundheitswesen die 47mrdeurochance fur Österreich.
  • BGW miab für die Pflege und den stationären Wohnbereich der Behindertenhilfe Erstveröffentlichung 2002, Stand 01/2013 Hrsg. Berufsgenossenschaft für Gesundheitsdienst und Wohlfahrtspflege (BGW). Hamburg, Online: www.bgw-online.de

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 7, 2025

Primary Completion (Actual)

June 29, 2025

Study Completion (Actual)

June 29, 2025

Study Registration Dates

First Submitted

December 6, 2024

First Submitted That Met QC Criteria

December 6, 2024

First Posted (Actual)

December 11, 2024

Study Record Updates

Last Update Posted (Estimated)

September 24, 2025

Last Update Submitted That Met QC Criteria

September 19, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • FHCW EC Nr. 130/2023

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Because the trial deals with sensitive health-related data, neither person-identifiable nor coded raw data will be made publicly available or shared upon request from other researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Medication Management at Home

Clinical Trials on medication management

Subscribe